First indigenous vaccine by INDIA targeted to launch by August 15, with the Indian Council of Medical Research (ICMR) fast-tracking efforts to develop “Covaxin” in partnership with Bharat Biotech International Limited. Twelve institutes have been selected for clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine), according to the government’s medical research body.
“The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the pre-clinical as well as clinical development of this vaccine,” ICMR mentioned in a letter to the institutes.
According to the PTI report, ICMR mentioned that it is envisaged to launch the vaccine for public health use latest by August 15, after completion of all clinical trials.
- Indian railway to launch “Made in India” rails, better than European standards
- The new programme was an attempt to minimize the loss to the education and experience of classroom learning’; Manish Sisodia
Prime Minister Narendra Modi had recently held a high-level meeting to take stock on the indigenous vaccine efforts.
This vaccine will prove out to be a bonanza for the nation and its citizens if it completed its human trials that are currently being prioritized by the government of India.
India reported the highest-ever single day spike of 20,903 COVID-19 cases, according to the data released by the Union Ministry of Health and Family Welfare. India’s tally has crossed 6 lakh mark, with confirmed cases more than 18 thousand fatalities.